These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20566794)

  • 1. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.
    Ringe KI; Husarik DB; Sirlin CB; Merkle EM
    AJR Am J Roentgenol; 2010 Jul; 195(1):13-28. PubMed ID: 20566794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver.
    Cruite I; Schroeder M; Merkle EM; Sirlin CB
    AJR Am J Roentgenol; 2010 Jul; 195(1):29-41. PubMed ID: 20566795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?
    Bashir MR; Husarik DB; Ziemlewicz TJ; Gupta RT; Boll DT; Merkle EM
    J Magn Reson Imaging; 2012 Mar; 35(3):611-6. PubMed ID: 22034383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal?
    Ringe KI; Husarik DB; Gupta RT; Boll DT; Merkle EM
    Eur J Radiol; 2011 Aug; 79(2):201-5. PubMed ID: 20347540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetate uptake as a possible marker of hepatocyte damage after liver resection-preliminary data.
    Bickelhaupt S; Studer P; Kim-Fuchs C; Candinas D; Froehlich JM; Patak MA
    Clin Radiol; 2013 Nov; 68(11):1121-7. PubMed ID: 23932672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
    Kim MJ; Rhee HJ; Jeong HT
    AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein.
    Feuerlein S; Boll DT; Gupta RT; Ringe KI; Marin D; Merkle EM
    AJR Am J Roentgenol; 2011 Jan; 196(1):W18-24. PubMed ID: 21178026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.
    Choi Y; Huh J; Woo DC; Kim KW
    Br J Radiol; 2016; 89(1058):20150666. PubMed ID: 26693795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine.
    Scali EP; Walshe T; Tiwari HA; Harris AC; Chang SD
    Can Assoc Radiol J; 2017 Aug; 68(3):293-307. PubMed ID: 28583364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?
    Haradome H; Grazioli L; Al manea K; Tsunoo M; Motosugi U; Kwee TC; Takaraha T
    J Magn Reson Imaging; 2012 Jan; 35(1):132-9. PubMed ID: 21960465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primovist, Eovist: what to expect?
    Van Beers BE; Pastor CM; Hussain HK
    J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Kitamura T; Araki T
    J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pediatric liver lesions with gadoxetate disodium.
    Meyers AB; Towbin AJ; Serai S; Geller JI; Podberesky DJ
    Pediatr Radiol; 2011 Sep; 41(9):1183-97. PubMed ID: 21701987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.